cervix uterine cancer
Let an agent explain cervical cancer and its prevention in general terms from oncology and public health guidelines, describe screening, symptoms, diagnosis and treatment, and route personal questions to clinicians.
Research draft, second pass
A second pass drafted this model: the structure a model of this thing needs, and what is known about it in the world. The line under this one says how the second half was obtained - researched against sources, or recalled without web access, in which case nothing here was read anywhere and every claim is a lead to verify. Unreviewed either way.
written by Claude from model knowledge without web access - no source was read, every claim is a lead to verify
Researched by: Claude
Purpose and description
Let an agent explain cervical cancer and its prevention in general terms from oncology and public health guidelines, describe screening, symptoms, diagnosis and treatment, and route personal questions to clinicians.
A cancer arising from the cervix, the lower part of the uterus, almost always caused by persistent infection with high-risk human papillomavirus types, mostly squamous cell carcinoma and adenocarcinoma with rare types such as neuroendocrine carcinoma, carcinosarcoma and melanoma, preventable by HPV vaccination and detectable early by screening with cytology and HPV testing, and more frequent in women with HIV as an AIDS-defining cancer; cervical cancer remains a leading cause of cancer death in low-income countries and is targeted for elimination by WHO.
What it is for: Not applicable; a cancer.
It can be explain the cancer and causes; relay prevention and screening; relay treatment and outcomes; route personal questions.
Distinguishing features
HPV causation
Vaccine preventable
Screen detectable
Global inequity
What it looks like
Not a visible object; abnormal cells or a tumour of the cervix.
Physical character
new cases worldwide: about 660000 per year - GLOBOCAN 2022
deaths worldwide: about 350000 per year
HPV-attributable share: over 95 percent
How it is recognised
Cancer of the uterine cervix
Squamous cell carcinoma, adenocarcinoma, neuroendocrine carcinoma, carcinosarcoma, melanoma; AIDS-related cervical cancer
Cervical intraepithelial neoplasia is precancerous; endometrial cancer arises in the uterine body
Related models
is a kind of - in registry terms
is a kind of - in registry terms
is caused by - high-risk types
is prevented by - and screening
In practice
Families and kinds
squamous cell carcinoma of the cervix
cervical adenocarcinoma
rare types such as neuroendocrine carcinoma, carcinosarcoma and melanoma
AIDS-related cervical cancer
precancerous cervical intraepithelial neoplasia
benign lesions such as cervical adenomyoma as distinct entities
Identifiers
ICD-11 2C77 malignant neoplasms of cervix uteri
MeSH D002583 uterine cervical neoplasms
Standards and regulation
WHO cervical cancer elimination strategy
National screening programmes
HPV vaccination schedules
ESGO, NCCN and other oncology guidelines
Failure modes and hazards
Missed screening
Agents giving personal medical advice
Vaccine misinformation
Inequitable access to screening and treatment
Also called
Where this came from
wikidata · CC0 1.0
Drafted structure
Bundle to layer to finding to question, as the second pass will find it: 4 bundles · 8 layers · 8 findings · 16 questions.
Help Getting help first.
Safety.
Signs
Warning signs.
Signs
Signs.
- What symptoms, such as abnormal bleeding or discharge, need prompt assessment? action
- Is the user describing such symptoms, which need a clinician promptly? boundary
Screening
Screening.
Screening
Screening.
- How do cytology and HPV screening programmes work, and who is invited? provenance
- Is the user asking about their own results, which need their clinician? boundary
Understand The cancer.
Clinical.
Causes
Causes and types.
Causes
Causes.
- How does HPV cause cervical cancer, and what types including rare forms exist? definition
- Is the question about cervical cancer, precancer or endometrial cancer? boundary
Risk
Risk factors.
Risk
Risk.
- What factors such as HIV, smoking and lack of screening increase risk? provenance
- Which entry fits the specific risk factor? action
Treat Prevention and treatment.
Clinical.
Prevention
Vaccination.
Prevention
Prevention.
- How does HPV vaccination prevent cervical cancer, and what does WHO recommend? provenance
- Which references are standard? provenance
Treatment
Treatment.
Treatment
Treatment.
- What treatments do guidelines recommend by stage, from surgery to chemoradiation and immunotherapy, in general terms? provenance
- Which sources are cited? provenance
Context Global health and history.
Context.
Global
Global elimination.
Global
Global.
- What is the WHO elimination strategy, and how does burden vary worldwide? provenance
- Which entry fits global cancer control? action
History
History.
History
History.
- How did the Pap test and the discovery of HPV causation change cervical cancer? provenance
- Which entry fits the history of cancer screening? action
What the second pass must settle
- Should HPV vaccine and cervical screening be separate primary entries?
- How should WHO and oncology guidelines be linked?
- The registry entry has merged aliases naming rare types and a benign lesion; should they be split off?